All Pharma News
Selecta Biosciences Announces Merger with Cartesian Therapeutics

Selecta Biosciences Announces Merger with Cartesian Therapeutics
GLOBENEWSWIRE
13 Nov 2023
Share Share
Selecta fuses with Cartesian in reverse merger

Selecta fuses with Cartesian in reverse merger
Max Bayer FIERCE BIOTECH
13 Nov 2023
Share Share
Selecta Announces Transition of Clinical Operations of ImmTOR for SEL-212

Selecta Announces Transition of Clinical Operations of ImmTOR for SEL-212
GLOBENEWSWIRE
31 Oct 2023
Share Share
Selecta narrows focus to gout drug, freezing rest of pipeline

Selecta narrows focus to gout drug, freezing rest of pipeline
James Waldron FIERCE BIOTECH
17 Aug 2023
Share Share
Selecta Biosciences Reports Second Quarter 2023 Financial Results

Selecta Biosciences Reports Second Quarter 2023 Financial Results
GLOBENEWSWIRE
17 Aug 2023
Share Share
Selecta Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212

Selecta Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212
GLOBENEWSWIRE
31 May 2023
Share Share
Selecta Biosciences Reports 1Q 2023 FYR and Provides Business Update

Selecta Biosciences Reports 1Q 2023 FYR and Provides Business Update
GLOBENEWSWIRE
04 May 2023
Share Share
Selecta lets go 25% of workforce, pauses PhI/II gene therapy trial

Selecta lets go 25% of workforce, pauses PhI/II gene therapy trial
Paul Schloesser ENDPTS
04 May 2023
Share Share
Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon

Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon
Nick Paul Taylor FIERCE BIOTECH
22 Mar 2023
Share Share
Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout Meets Endpoint

Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout Meets Endpoint
GLOBENEWSWIRE
21 Mar 2023
Share Share